Video Latest - ecancer

OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more

Dr John Haanen, Dr Vivek Subbiah, Dr Christian Rolfo, Dr Jessica Hwang, Dr Nagla Karim, Dr Fumiko Chino, Dr Narjust Duma & Dr Nicole Kuderer

19 Jan 2022

OncoAlert Colloquium Day 4: GI oncology and EONS

Dr Cathy Eng, Dr Yelena Janjigian, Ms Stacy Hurt, Ms Allison Rosen, Dr Mark Lewis, Dr Nina Niu Sanford, Mr Johan de Munter & Dr Merel Van Klinken

19 Jan 2022

OncoAlert Colloquium Day 3: Breast cancer

Dr Erika Hamilton, Dr Bhawna Sirohi, Ms Ginny Mason RN, Dr Hope Rugo, Dr Sara Tolaney, Dr Matteo Lambertini & Dr Icro Meattini

19 Jan 2022

OncoAlert Colloquium Day 2: Lung cancer and MASCC

Dr Stephen Liu, Dr Jack West, Dr Sanay Popat, Dr Jarushka Naidoo, Dr Percy Lee, Ms Jill Feldman, Ms Ivy Elkins, Dr Andrew Davies & Dr Joanne Bowen

19 Jan 2022

OncoAlert Colloquium Day 1: Genitourinary cancers and geriatric oncology

Dr Toni Choueiri, Dr Andrea Apolo, Dr Neeraj Agarwal, Dr Piet Ost, Dr Sean McBride, Dr Ravindran Kanesvaran & Dr Nicolo Battisti

19 Jan 2022

The RxPONDER trial and its impact on best clinical practice

Prof Christos Markopoulos and Prof Giuseppe Curigliano

17 Dec 2021

WHO and St. Jude Children’s research hospital to dramatically increase global access to childhood cancer medicine

Dr Andre Llbawi - World Health Organization (WHO) Global Childhood Cancer Initiative

17 Dec 2021

The global platform for access to childhood cancer medicines

Dr James Downing - St. Jude Children’s Research Hospital, Memphis, USA

17 Dec 2021

Cancer medicine shortages for children around the world

Dr Carlos Rodriguez-Galindo - St. Jude Children’s Research Hospital, Memphis, USA

17 Dec 2021

Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic

Prof Richard Sullivan - Kings College London, London, UK & Dr Dorothy Lombe - Regional Cancer Treatment Service, Palmerston North, New Zealand

15 Dec 2021

Integrated genomic analysis identifies UBTF tandem duplications as a subtype-defining lesion in paediatric AML

Dr Masayuki Umeda - St. Jude Children's Research Hospital, San Francisco, USA

14 Dec 2021

EURO-SKI: 46% of CML patients still in molecular recurrence- and treatment-free survival 3 years after TKIs

Prof Francois-Xavier Mahon - University of Bordeaux, Bordeaux, France

13 Dec 2021

Video